Keith Li King-wah pledges to rebuild David Webb's 27-year database using AI, ensuring its integrity and free access, while the editorial side of Webb-site.com will cease as per Webb's wishes.
Former President Joe Biden's cancer has metastasized into his bones and is very painful, according to his son Hunter Biden in a BBC interview. The diagnosis follows a public announcement last May regarding his prostate cancer.
Le cancer de la prostate de l'ancien président américain Joe Biden s'est aggravé avec des métastases dans les os et au-delà, a indiqué son fils Hunter Biden dans un entretien à la BBC.
Former US President Joe Biden's aggressive prostate cancer has metastasized into his bones and further, according to an update from his son Hunter Biden in a BBC interview.
L'ancien président américain Joe Biden, 83 ans, voit son cancer de la prostate s'être propagé « au-delà de ses os » et est décrit comme « très douloureux » par son fils Hunter dans une interview à la BBC.
Hunter Biden shares that his father, former US President Joe Biden, 83, is experiencing painful and debilitating metastasized prostate cancer, now spread to his bones.
Australia updates prostate cancer detection guidelines, expanding PSA testing eligibility to men aged 45-69 and those over 70 with a life expectancy over 7 years, aiming to improve early diagnosis and reduce over-diagnosis.
A new study in the British Journal of Ophthalmology reveals that men using erectile dysfunction and prostate drugs like tadalafil long-term are 22 per cent more likely to develop glaucoma.
Six-time Olympic cycling champion Sir Chris Hoy shares his experience living with stage 4 prostate cancer, advocating for better screening and raising funds for research while navigating his own health challenges and family life.
Philip Kong, a 75-year-old Hong Kong retiree, discovered that prostate surgery at The University of Hong Kong-Shenzhen Hospital could cost nearly 90% less than in Hong Kong, highlighting significant healthcare cost disparities between the two cities.
Hong Kong retiree Philip Kong, 75, discovered he could reduce his prostate surgery bill by up to 90% by opting for treatment at the University of Hong Kong-Shenzhen Hospital rather than a Hong Kong facility, prompting him to reflect on local healthcare costs.
Dermot Murnaghan, a veteran TV presenter known for his work on BBC, ITV, and Sky News, has died at the age of 68. He passed away peacefully at home in North London, a year after revealing his stage four prostate cancer diagnosis. Murnaghan was an advocate for men's health, urging them to get tested for prostate cancer.
Dermot Murnaghan, a veteran BBC and Sky News presenter known for hosting "Eggheads", has died at the age of 68. His family announced his passing, stating he died peacefully at home in north London after a period of illness with prostate cancer. Murnaghan publicly shared his stage four prostate cancer diagnosis last year.
Dermot Murnaghan, a veteran TV presenter known for his work on BBC, ITV, and Sky News, has died at the age of 68. He had been diagnosed with stage four prostate cancer a year ago and was an advocate for early testing.
Hong Kong researchers are developing an affordable blood test for prostate cancer, aiming to reduce the need for invasive biopsies. The technology is expected to launch in about two years, offering a less uncomfortable diagnostic process for patients like Peter Wan, who experienced a lengthy and invasive journey to his diagnosis.
Jeremy Clarkson announced he is in remission from prostate cancer, days after revealing his diagnosis. The TV presenter shared on Clarkson's Farm that he had an aggressive form diagnosed in 2025, but follow-up tests confirmed he is cancer-free.
Jeremy Clarkson, the renowned British presenter, has revealed he has been diagnosed with aggressive but early-stage prostate cancer. He announced the news during the latest episode of his Amazon Prime Video series, 'Clarkson's Farm,' stating he has known since May and underwent surgery, with the outcome still uncertain.
A large-scale study from Harvard University suggests that men ejaculating over 21 times per month may have a 19-22% lower risk of developing low-risk prostate cancer. However, frequent ejaculation showed no significant protective effect against high-risk or metastatic prostate cancer. Urologist Huang Po-jen emphasizes that this is an observational study showing correlation, not causation, and advises against deliberately altering ejaculation frequency for cancer prevention. He recommends a healthy lifestyle and regular screenings as the primary methods for prostate cancer prevention.
Thousands of men in England diagnosed with low- or intermediate-risk prostate cancer will be offered SABR, a precision radiotherapy that reduces treatment sessions from 20 to five. This advanced technique targets the disease more effectively, minimizing side effects and allowing patients to return to normal life sooner. NHS England expects all 48 radiotherapy centers to offer the treatment within weeks.
UK health secretary backs UKNSC recommendation against population-wide PSA screening, opting for targeted testing of high-risk BRCA2 mutation carriers. Funding is increased for the Transform trial to include more Black men, addressing concerns about health inequalities.
Tens of thousands more black men aged 45-74 in the UK will be invited for prostate cancer checks as part of an £18 million government-funded trial. The move aims to find better testing methods for the disease, which disproportionately affects black men.
Le cancer de la prostate, fréquent et meurtrier chez les hommes, soulève la question de son dépistage systématique. Le test PSA, bien qu'utilisé pour le diagnostic précoce, fait débat en raison de ses faux positifs et de la lenteur d'évolution de nombreux cancers.
Cancer claims 10 million lives annually, with varying deadliness. New drugs show promise for pancreatic and head/neck cancers, and precision medicine is advancing. However, a global shortfall of 100 million healthcare workers by 2050 and treatment delays are critical issues. Worryingly, cancer rates are rising in those under 50, linked to environmental factors.
UK's National Screening Committee recommends prostate cancer screening via PSA blood test only for men with BRCA2 gene variant and family history of specific cancers, citing harms outweighing benefits in other groups.
